Neurogene Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| 667, L.P. | — | Purchase | 2,767,505 | $8.40 | $23,247,042 | 12,872,664 | Dec 20, 2019 |
| DRACHMAN JONATHAN G | See Remarks | Purchase | 36,742 | $3.08 | $113,165 | 447,992 | Sep 9, 2019 |
| DRACHMAN JONATHAN G | See Remarks | Award / Grant | 568,039 | — | — | 568,039 | Aug 8, 2019 |
| DRACHMAN JONATHAN G | President and CEO | Award / Grant | 7,428 | — | — | 7,428 | Aug 8, 2019 |
| BAKER FELIX | — | Purchase | 531 | $2.96 | $1,572 | 1,177,013 | Aug 6, 2019 |
| LEVITT DANIEL J | — | Option Exercise | 3,906 | $10.56 | $41,247 | 3,906 | May 14, 2018 |
| MacKenzie Lloyd | Chief Operating Officer | Sale | 1,302 | $14.63 | $19,048 | — | Mar 15, 2018 |
| Main David | President and CEO | Sale | 3,625 | $13.16 | $47,705 | 71,530 | Jun 2, 2017 |
| BAKER BROS. ADVISORS LP | — | Purchase | 9,143 | $16.20 | $148,117 | 9,441,725 | Jan 9, 2017 |
| BAKER FELIX | — | Purchase | 2,476,348 | $12.25 | $30,335,263 | 9,404,467 | Sep 20, 2016 |
| BAKER BROS. ADVISORS LP | — | Purchase | 185,413 | $7.91 | $1,466,617 | 6,799,144 | Mar 15, 2016 |
| Baker Bros. Advisors (GP) LLC | — | Purchase | 1,887 | $10.78 | $20,342 | 765,980 | Jan 25, 2016 |
| BAKER BROS. ADVISORS LP | — | Purchase | 5,029 | $9.08 | $45,663 | 750,354 | Jan 20, 2016 |
| BAKER FELIX | — | Purchase | 330 | $8.08 | $2,666 | 736,927 | Jan 15, 2016 |
| BAKER JULIAN | — | Purchase | 2,998 | $8.08 | $24,224 | 6,128,358 | Jan 14, 2016 |
| Bridger Gary | — | Other | 1,543,989 | — | — | — | Oct 31, 2015 |
| BAKER FELIX | — | Purchase | 2,213,469 | $15.50 | $34,308,770 | 6,022,104 | Sep 10, 2015 |
| Mitchell David Chilton | VP Global Regulatory & Quality | Purchase | 3,575 | $17.81 | $63,671 | 3,575 | Aug 24, 2015 |
| MacKenzie Lloyd | VP Technical Operations | Option Exercise | 7,812 | $5.76 | $44,997 | 7,812 | Aug 12, 2015 |
| Alam Kamran | CFO, Vice President Finance | Option Exercise | 20,833 | $5.76 | $119,998 | 29,079 | Aug 12, 2015 |
| Mitchell David Chilton | VP Global Regulatory & Quality | Purchase | 1,600 | $24.36 | $38,976 | 1,600 | Aug 11, 2015 |
| JOHNSON & JOHNSON | — | Sale | 231,455 | $31.66 | $7,327,865 | 1,383,366 | Aug 11, 2015 |
| PFIZER INC | — | Sale | 18 | $29.00 | $522 | 1,235,312 | Aug 10, 2015 |
| JOHNSON & JOHNSON | — | Sale | 6,507 | $7.63 | $49,648 | 1,343,687 | Dec 17, 2014 |
| JOHNSON & JOHNSON | — | Sale | 3,645 | $7.51 | $27,374 | 1,350,194 | Dec 11, 2014 |
| JOHNSON & JOHNSON | — | Sale | 1,300 | $7.70 | $10,010 | 1,355,194 | Dec 8, 2014 |
| JOHNSON & JOHNSON DEVELOPMENT CORP ET AL | — | Sale | 1,627 | $7.75 | $12,609 | 1,377,767 | Dec 5, 2014 |
| JOHNSON & JOHNSON DEVELOPMENT CORP ET AL | — | Sale | 1,200 | $7.54 | $9,048 | 1,379,394 | Dec 1, 2014 |
| JOHNSON & JOHNSON DEVELOPMENT CORP ET AL | — | Sale | 1,500 | $7.80 | $11,700 | 1,381,094 | Nov 26, 2014 |
| JOHNSON & JOHNSON DEVELOPMENT CORP ET AL | — | Sale | 2,400 | $8.25 | $19,800 | 1,386,594 | Nov 24, 2014 |
| SHREWSBURY STEPHEN B | CMO; Senior VP Clinical Dev. | Purchase | 400 | $8.22 | $3,288 | 400 | Sep 2, 2014 |
| JOHNSON & JOHNSON | — | C | 1,392,094 | — | — | 1,392,094 | Mar 12, 2014 |
| Ventures West 8 Limited Partnership | — | Disposition | 189,393 | — | — | — | Mar 12, 2014 |
| Bridger Gary | — | Disposition | 189,393 | — | — | — | Mar 12, 2014 |
| PFIZER INC | — | C | 962,603 | — | — | 962,603 | Mar 12, 2014 |
| Main David | President and CEO | Disposition | 9,459 | $11.00 | $104,049 | 71,530 | Mar 12, 2014 |
| JOHNSON & JOHNSON | — | C | 1,392,094 | — | — | 1,392,094 | Mar 12, 2014 |